Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,201.20
-73.70 (-3.24%)
Jun 1, 2026, 3:29 PM IST
Glenmark Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Glenmark Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of ₹2,300. The average 1-year stock price forecast is 4.49% higher than the current stock price, while the lowest is ₹1,640 (-25.50%) and the highest is ₹2,735 (+24.25%).
Price Target: ₹2,300 (+4.49%)
Analyst Consensus: Buy
* Price targets were last updated on Feb 3, 2026.
Analyst Ratings
The average analyst rating for Glenmark Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 3 | 3 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 12 | 12 | 12 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| ICICI Securities | ICICI Securities | Sell Maintains ₹1,640 | Sell | Maintains | ₹1,640 | -25.50% | Feb 3, 2026 |
Unknown Analyst Motilal Oswal No rating | Motilal Oswal | Buy Maintains ₹2,240 | Buy | Maintains | ₹2,240 | +1.76% | Feb 2, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.